About Mogens Gisselbaek, MD, MSc
Founder, Gisselbaek Consulting – Fractional CMO & Medical Director
I help biotech, medtech and specialty pharma companies access senior clinical and medical leadership at the moments where development decisions define enterprise value.
After more than two decades in global pharma and medtech, I founded Gisselbaek Consulting to support organisations that need CMO-level ownership of both strategy and execution — without hiring a full-time CMO.
My career includes roles such as:
Senior Director in Global Clinical Drug Development at Novo Nordisk
Chief Medical Officer in an orthopaedic biotech
Medical Director / Medical Affairs leader in several international companies
I have led global development programmes, overseen clinical trial portfolios from Phase I–IV, built Medical Affairs organisations and been accountable for medical and scientific review in high-visibility environments.
My perspective on value creation
Different innovation models require different development logics:
- Internal innovation → progressive value creation over time
- External innovation → value realisation through focused execution
- Biotech → conversion of runway into value inflection points
- Partnerships → governance as a core value driver
The objective is always the same: maximise enterprise value.
What changes is how the organisation must be set up — and how the development path is designed — to achieve it.
How I work
I am hands-on, collaborative and pragmatic.
I integrate with your existing team, CROs and advisors and take responsibility for decisions, progress and external credibility.
My focus is always on what matters most for:
- patients
- regulators
- Payers
- Prescribers
- investors
- and your company’s next value inflection point
If you are building or scaling a biotech, medtech or specialty pharma company and need senior clinical or medical leadership, I would be happy to explore how we can work together.